Details of the Drug Reposition

General Information of This Drug (ID: DMTIVEN)

• Drug Name: Metronidazole (DMTIVEN)
• Synonyms: APMN; Acromona; Anagiardil; Arilin; Atrivyl; Bexon; CONT; Clont; Danizol; Deflamon; Efloran; Elyzol; Entizol; Eumin; Flagemona; Flagesol; Flagil; Flagyl; Flegyl; Florazole; Fossyol; Giatricol; Gineflavir; Giniflavir; Klion; Klont; Meronidal; Methronidazole; Metric; MetroCream; MetroGel; MetroLotion; Metrodzhil; Metrogyl; Metrolag; Metrolyl; Metromidol; Metronidaz; Metronidazol; Metronidazolo; Metronidazolum; Metrotop; Metrozine; Metryl; Mexibol; Monagyl; Monasin; NIDA; Nalox; Nidagel; Noritate; Novonidazol; Orvagil; Protostat; Rathimed; Rosased; Sanatrichom; Satric; Takimetol; Trichazol; Trichex; Trichocide; Trichomol; Trichopal; Trichopol; Tricocet; Tricom; Trikacide; Trikamon; Trikojol; Trikozol; Trimeks; Trivazol; Vagilen; Vagimid; Vandazole; Vertisal; Wagitran; Zadstat; Zidoval; Flagyl Er; Ginefla vir; METRONIDAZOLE USP; Metro Cream; Metro Gel; Metronidazole Monohydrochloride; Metronidazole Phosphoester; Metronidazole in Plastic Container; Metronidazolo [DCIT]; Tricho cordes; Trichomonacid pharmachim; Tricowas B; Bayer 5360; Flagyl 375; M0924; Metric 21; RP 8823; SC 10295; Anabact (TN); Apo-Metronidazole; Deflamon-wirkstoff; Flagyl (TN); IDR-90105; METRO I.V; MetroGel (TN); MetroGel-Vaginal; Metronidazol [INN-Spanish]; Metronidazolum [INN-Latin]; Mexibol (silanes); Neo-Tric; Noritate (TN); RP-8823; Rozex (TN); Tricho-gynaedron; ZERO/004064; CB-01-14 MMX; FLAGYL I.V. RTU IN PLASTIC CONTAINER; Flagyl I.V.; Flagyl I.V. RTU; Metro I.V.; Metro I.V. In Plastic Container; Metrogel-vaginal (TN); Metronidazole (JP15/USP/INN); Metronidazole [USAN:INN:BAN:JAN]; Methyl-5-nitroimidazole-1-ethanol; 1-Hydroxyethyl-2-methyl-5-nitroimidazole; 2-(2-methyl-5-nitroimidazol-1-yl)ethanol; 2-Methyl-5-nitro-1-imidazoleethanol; 2-Methyl-5-nitroimidazole-1-ethanol; MNZ
• Therapeutic Class: Antiinfective Agents
• Drug Type: Small molecular drug

Information on Drug Reposition of This Drug

10 Approved Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Trichomoniasis	DIS9HBNL	N.A.	Approved	[1]
Peritonitis	DISMCMLQ	N.A.	Approved	[1]
Liver abscess (disease)	DISIPHX6	N.A.	Approved	[1]
Endometritis	DISHGJ6G	N.A.	Approved	[1]
Bladder squamous cell carcinoma	DIS5UKG5	N.A.	Approved	[1]
Anaerobic bacteria infectious disease	DIS0O0AU	N.A.	Approved	[1]
Abscess	DISAP982	N.A.	Approved	[1]
Amoebiasis	DISAJWJL	1A36	Approved	[2]
Bacteremia	DIS6N9RZ	1A73	Approved	[1]
Bacterial vaginosis	DISK2MZ2	MF3A	Approved	[1]

1 Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Perianal crohn disease	DISOV578	DD70.4	Phase 3	[3]

2 Withdrawn Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Bladder adenocarcinoma	DISZ8H0T	N.A.	Withdrawn	[4]
Peritonsillar abscess	DISZZXTZ	N.A.	Withdrawn	[5]

1 Discontinued in Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Bladder transitional cell carcinoma	DISNL46A	N.A.	Discontinued in Phase 2	[6]

1 Investigative Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Giardiasis	DISWUNWK	N.A.	Investigative	[1]

References

• [1] Metronidazole FDA Label
• [2] FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 018517.
• [3] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [4] A Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome
• [5] Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer
• [6] Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's Lymphoma